BIOMAT Database Logo BIOMAT Database Logo

Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study. 1994

J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Laboratory of Medicinal Chemistry, University of Liège, Belgium.

In order to characterize the pharmacological profile of the different chemical classes of pyridobenzazepine derivatives, a series of N-methylpiperazinopyrido[1,4]- and -[1,5]- benzoxa- and benzothiazepine derivatives were prepared. The affinities for D2, D1, 5-HT2, and cholinergic (M) receptors were measured. In comparison to dibenzazepine reference compounds, a strong decrease of the affinities was observed, less pronounced, however, for the substituted analogues. Oxazepine and thiazepine analogues like clozapine (except 8-chloro-6-(4-methylpiperazin-1-yl)-pyrido[2,3-b][1,4]benzoxazepin e (9) and 8-chloro-6-(4-methylpiperazin-1-yl)pyrido[2,3-b][1,4]- benzothiazepine (11)) were found to be inactive against apomorphine stereotypies. In the open-field test in rats, different molecules showed a high disinhibitory activity as observed with anxiolytic drugs. Moreover, 8-chloro-5-(4-methylpiperazin-1-yl)pyrido[2,3-b][1,5]benzoxazepine (14) presented a clozapine-like profile that was confirmed in the behavioral model in dogs and showed most of the behavioral characteristics described for antipsychotic drugs. Its neurochemical profile, in particular the 5-HT2/D2 ratio, was also compatible with atypical antipsychotic activity.

UI MeSH Term Description Entries
D010077 Oxazepines
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013841 Thiazepines Compounds that are derivatives of THIEPINS, with a nitrogen replacing a carbon in the seven-membered heterocyclic compound. Thiazepine

Related Publications

J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Pyrimidine derivatives as potential agents acting on central nervous system.
January 2015, Central nervous system agents in medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Thiazolidin-4-one Derivatives as Central Nervous System Potential Agents.
February 2015, Central nervous system agents in medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Potential central nervous system antitumor agents. Hydantoin derivatives.
August 1975, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Synthesis of nitrosourea derivatives of sucrose as central nervous system anticancer agents.
October 1977, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 4. Central nervous system depressants.
November 1978, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents.
November 1976, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Diazenyl derivatives as therapeutic and diagnostic agents acting on central nervous system.
January 2015, Central nervous system agents in medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Potential central nervous system antitumor agents. Aziridinylbenzoquinones.
November 1976, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
February 1976, Journal of medicinal chemistry,
J F Liégeois, and F A Rogister, and J Bruhwyler, and J Damas, and T P Nguyen, and M O Inarejos, and E M Chleide, and M G Mercier, and J E Delarge
Preparation of alkoxyquinoline derivatives and their evaluation as potential central nervous system stimulants.
November 1984, Journal of pharmaceutical sciences,
Copied contents to your clipboard!